Reuters logo
4 个月前
BRIEF-Windtree Therapeutics reports Q4 loss per share $0.77
2017年3月31日 / 中午11点43分 / 4 个月前

BRIEF-Windtree Therapeutics reports Q4 loss per share $0.77

1 分钟阅读

March 31 (Reuters) - Windtree Therapeutics Inc

* Windtree Therapeutics reports fourth quarter 2016 financial results and provides key business updates

* Q4 loss per share $0.77

* Q4 revenue $900,000 versus $700,000

* Windtree Therapeutics-existing cash resources sufficient to fund operations through completion of aerosurf phase 2b clinical trial,results in mid-2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below